The Medical Device sector has been humming. Granted, it comprises a huge range of things, from hip and knee joints to cardiovascular devices. Since 2016, 176 deals have been announced, and $102 billion has been committed based on 73 disclosed prices. Among the 176 deals, 14 target companies specialize in cardiovascular devices, 14 specialize in orthopedic […]
Spending on health care deals in April 2017 rose sharply compared with the month before, thanks to a couple of big deals.
Becton, Dickinson’s $24 billion deal for C.R. Bard helps it expand into markets outside the United States, and to treat diseases beyond diabetes.
Deals for medical device companies have slowed considerably since 2016. The sector seems to be gaining new life as the second quarter of 2017 begins.